Register entryRepackager / relabeller
Kesin Pharma Corporation
- Registered sites
- 1
- Drug products
- 44
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
LabellingPackagingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Kesin Pharma Corporation | Oldsmar, FLUnited States | Labelling, Packaging, Repackaging | 3016965788 |
Catalogue
Marketed products
44Showing 44 of 44.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Atovaquone | Atovaquone | SUSPENSION | ANDA |
| Atovaquone Oral Suspension | Atovaquone | SUSPENSION | ANDA |
| CHILDRENS Acetaminophen | CHILDRENS Acetaminophen | SUSPENSION | OTC MONOGRAPH DRUG |
| CHILDRENS Ibuprofen | Ibuprofen | SUSPENSION | ANDA |
| Chlorhexidine Gluconate, 0.12% Oral Rinse Solution | Chlorhexidine Gluconate, 0.12% Oral Rinse | SOLUTION | ANDA |
| Dexamethasone | Dexamethasone | ELIXIR | ANDA |
| Dextromethorphan HBr and Guaifenesin Oral Solution | Dextromethorphan HBr and Guaifenesin Oral Solution | LIQUID | OTC MONOGRAPH DRUG |
| Diphenhydramine HCl Oral Solution | Diphenhydramine HCl Oral Solution | SOLUTION | OTC MONOGRAPH DRUG |
| Docusate Sodium Oral Liquid | Docusate Sodium Oral Liquid | LIQUID | OTC MONOGRAPH DRUG |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | GRANULE, FOR SOLUTION | ANDA |
| Gabapentin | Gabapentin | SOLUTION | ANDA |
| Gabapentin | Gabapentin | SOLUTION | ANDA |
| Guaifenesin | Guaifenesin | LIQUID | OTC MONOGRAPH DRUG |
| Hydroxyzine Hydrochloride | Hydroxyzine Hydrochloride | SOLUTION | ANDA |
| Kesin MAG-AL | Aluminum and Magnesium Hydroxide Suspension | SUSPENSION | OTC MONOGRAPH DRUG |
| Kesin MAG-AL Plus | Aluminum and Magnesium Hydroxide w/Simethicone Suspension | SUSPENSION | OTC MONOGRAPH DRUG |
| Kesin MAG-AL Plus XS | Aluminum and Magnesium Hydroxide w/Simethicone Suspension | SUSPENSION | OTC MONOGRAPH DRUG |
| LEVETIRACETAM | LEVETIRACETAM | SOLUTION | ANDA |
| LIKMEZ | Metronidazole Oral | SUSPENSION | NDA |
| Lacosamide Oral Solution | Lacosamide | SOLUTION | ANDA |
| Lacosamide Oral Solution | Lacosamide | SOLUTION | ANDA |
| Lactulose Solution | Lactulose Solution USP, 10 g/15 mL | SOLUTION | ANDA |
| Loperamide Hydrochloride | Loperamide Hydrochloride | SOLUTION | ANDA |
| Magnesium Oxide | Magnesium Oxide | TABLET | OTC MONOGRAPH DRUG |
| Megestrol Acetate | Megestrol Acetate | SUSPENSION | ANDA |
| Milk of Magnesia | Magnesium Hydroxide | SUSPENSION | OTC MONOGRAPH DRUG |
| Mineral Oil | Mineral Oil | SOLUTION | OTC MONOGRAPH DRUG |
| Mupirocin | Mupirocin Ointment | OINTMENT | ANDA |
| NYSTATIN | NYSTATIN | SUSPENSION | ANDA |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | SOLUTION | ANDA |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | SOLUTION | ANDA |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | SOLUTION | ANDA |
| Phenobarbital Oral Solution | Phenobarbital Oral | SOLUTION | UNAPPROVED DRUG OTHER |
| Phenobarbital Oral Solution | Phenobarbital Oral | SOLUTION | UNAPPROVED DRUG OTHER |
| Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | POWDER, FOR SOLUTION | ANDA |
| Potassium Chloride | Potassium Chloride | POWDER, FOR SOLUTION | ANDA |
| Senna Syrup | Senna Syrup | SYRUP | OTC MONOGRAPH DRUG |
| Sodium Chloride | Sodium Chloride Tablets | TABLET | UNAPPROVED DRUG OTHER |
| Sodium Citrate and Citric Acid | Sodium Citrate and Citric Acid | SOLUTION | UNAPPROVED DRUG OTHER |
| Sucralfate | Sucralfate | SUSPENSION | ANDA |
| Sulfamethoxazole and Trimethoprim | Sulfamethoxazole and Trimethoprim | SUSPENSION | ANDA |
| TOPIRAMATE | TOPIRAMATE | SOLUTION | ANDA |
| Valproic Acid | Valproic Acid | SOLUTION | ANDA |
| prednisoLONE sodium phosphate | prednisoLONE sodium phosphate | SOLUTION | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.